An original stem cell study provides insight into Klinefelter syndrome.

Published Date: 05 Apr 2023

Scientists have conducted a first-of-its-kind study in a collaboration between King Abdullah University of Science and Technology (KAUST), King Abdulaziz University, Jeddah (KAU), and King Abdulaziz University Hospital, Jeddah (KAUH).

Read Full News

Latest News

New Breathalyzer Detects When Your Body Is Burning Fat

A hand-held device that measures acetone levels in your breath — signaling ketosis — matched mass spectrometry tests for accuracy. But clinical uses may be limited for now.

Over-the-Counter Continuous Glucose Monitors: Okay for Kids?

A pediatric endocrinologist raises questions about use in youth without diabetes.

One Ultrasound Scan Flags Both MASH and Liver Scarring

A novel ultrasound-derived score combined with liver stiffness measurement can identify both MASH and fibrosis, potentially reducing the need for biopsy.

Surprising Signal for Semaglutide in Bipolar Disorder

The GLP-1 semaglutide was linked to fewer psychiatric hospitalizations in patients with bipolar disorder, raising the possibility of benefits beyond weight loss and glycemic control.

Lumbar CT Surpasses MRI in Vertebral Bone Quality Assessment

Lumbar CT attenuation measurements outperform MRI-derived vertebral bone quality scores for diagnosing osteopenia and osteoporosis in degenerative spinal populations.
HTTP error: 503

Todays Updates

Faster 1-Hour MI Rule-Out Is Safe

The 1-hour troponin pathway was safely implemented in a real-world study but did not impact workflow in busy emergency departments.

Edoxaban Falls Short After Intracranial Hemorrhage in AF

Edoxaban reduced ischemic stroke after intracranial hemorrhage in patients with AF, but excess hemorrhagic stroke and major bleeding offset the benefit.

Drug Benefit Seen in Nonobstructive HCM

A multicenter phase 3 trial has associated a cardiac myosin inhibitor with meaningful clinical benefit in nonobstructive HCM, for which there has been no effective therapies.

Tailored Approach Shortens Endocarditis Therapy

Tailored antibiotic therapy for infective endocarditis was associated with a significant reduction in treatment duration, according to an open-label multicenter trial.

Todays Updates

Faster 1-Hour MI Rule-Out Is Safe

The 1-hour troponin pathway was safely implemented in a real-world study but did not impact workflow in busy emergency departments.

Edoxaban Falls Short After Intracranial Hemorrhage in AF

Edoxaban reduced ischemic stroke after intracranial hemorrhage in patients with AF, but excess hemorrhagic stroke and major bleeding offset the benefit.

Drug Benefit Seen in Nonobstructive HCM

A multicenter phase 3 trial has associated a cardiac myosin inhibitor with meaningful clinical benefit in nonobstructive HCM, for which there has been no effective therapies.

Tailored Approach Shortens Endocarditis Therapy

Tailored antibiotic therapy for infective endocarditis was associated with a significant reduction in treatment duration, according to an open-label multicenter trial.

Latest News

HTTP error: 503

A pediatric endocrinologist raises questions about use in youth without diabetes.

A novel ultrasound-derived score combined with liver stiffness measurement can identify both MASH and fibrosis, potentially reducing the need for biopsy.

The GLP-1 semaglutide was linked to fewer psychiatric hospitalizations in patients with bipolar disorder, raising the possibility of benefits beyond weight loss and glycemic control.
HTTP error: 503HTTP error: 503

News All Time

HTTP error: 503HTTP error: 503

Partner Weight Loss Increases When Included in Program

A behavioral weight-loss program aimed at one partner can produce meaningful, lasting weight loss in the other — despite never asking them to change their own habits.

Fatigue, Brain Fog Persist in Women With Prolactinoma

Even with prolactin levels under control, many women with a prolactinoma still battle fatigue and concentration problems, a new Dutch cohort study reveals.

Is There a ‘Best’ GLP-1 Injection Site?

Experts say any of the three approved subcutaneous injection sites for GLP-1s will work, but users, and some social media influencers, have strong opinions about which is best.

More US Employers to Drop Weight-loss Drugs in 2027, as Healthcare Costs Increase

About 14% of employers in the United States have already or plan to drop GLP-1 drugs in 2027, as companies see ⁠rising healthcare costs, according to a survey released on...

Trump's Weight; Fauci Gets a Legal Defense Fund; Eye Drops Recalled

— Health news and commentary gathered by MedPage Today staff

Recognizing Patients With High Risk T1D: Clinical Indicators of IAH and Recurrent Severe Hypoglycemia

Recognizing Patients With High Risk T1D: Clinical Indicators of IAH and Recurrent Severe Hypoglycemia

Foundations and Frontiers in Acromegaly: Pathophysiology, Current Treatments, and Emerging SRLs

Foundations and Frontiers in Acromegaly: Pathophysiology, Current Treatments, and Emerging SRLs

Judge Questions Hegseth's Testosterone Policy Amid Military's Transgender Care Ban

Parties ordered to address "similarities and differences in administering TRT" to both groups

FDA Panel Endorses Lifting Restrictions on Peptides Backed by RFK Jr.

Votes go against agency scientists' recommendation to keep them off the compounding list
HTTP error: 503HTTP error: 503

Surgery Underused for Primary Hyperparathyroidism With End-Organ Damage, Study Says

Large study highlights gap between guidelines and clinical practice

Thyroid Meds Recalled Nationwide; Worst GLP-1 for Hair Loss? PMOS Prevalence

News and commentary from the endocrinology world

Florida Investigates Fauci; Obesity Drug Trial Sparks Lawsuit; 'Early Bird' Dinners

Health news and commentary gathered by MedPage Today staff

Recommended News For You

UK study evaluates effectiveness of cancer diagnosis pathway for patients with non-specific symptoms

'It's rare and it's scary.' Dark spot on your fingernail could mean cancer

What Do Patients Want Doctors to Know About Breast Cancer Recurrence?

Advanced Solid Tumors May Benefit from Investigative Immunotherapy Combo.

'Full House' Star's Cancer; Fluoride Fears Go Mainstream; Florida Doctor Arrested

Chemo-Free Quadruplet Shows Promise as DLBCL's First Therapy.

Efficacy and safety of intravenous chemotherapy in children with intraocular retinoblastoma

Recommended Articles For You

Cancer in 2024: Global Trends, Challenges, and Innovations for Healthcare Professionals 

Unlocking the Potential of Plinabulin: A New Frontier in Cancer Treatment 

Unlocking the Mystery of Granulomas: A Closer Look at the Causes and Treatment 

Case-Based Learning on Bone Marrow Recovery After Sequential Hematologic Interventions 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

AI-based liquid biopsy shows promise for detecting brain cancer

2.

To refute accusations that it failed to issue a cancer warning, Roundup's maker is asking lawmakers for assistance.

3.

Aspirin Fails to Boost Survival in Colorectal Cancer Trial

4.

Ignoring Colonoscopy Advice; Dry Mouth Acupuncture; Inflamed Tongue, Then Cancer.

5.

Males with early-onset colorectal cancer are at risk, according to a study.

1.

Advances in Cancer Detection: From Genetic Risk to Molecular Biomarkers

2.

Metabolic Reprogramming of the Tumor Microenvironment: Mechanisms, Clinical Relevance, and Emerging Therapeutic Strategies

3.

Multidisciplinary Insights into Diagnosis, Management, and Outcomes in Oncology

4.

Innovative Breakthroughs in Hematology for Modern Medicine

5.

Precision Erythropoietic Modeling for Hematologic Disorders

1.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

2.

International Cancer Conference

3.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Understanding the Role of Screening in Cancer Prevention

2.

Innovations in Hematology

3.

Summary of The Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2

4.

A Panel Discussion on Clinical Trial End Point for Tumor With PPS > 12 months

5.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VIII

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot